FibroGen Inc
FGEN
Market Cap$115.56M
Close$
$3.46
239.7% upside
Current Fair Value
239.7% upsideUndervalued by 239.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $115.56 Million |
|---|---|
| Enterprise Value | $-48,089,641.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.92 |
| Beta | 3.37 |
| Outstanding Shares | 98,771,247 |
| Avg 30 Day Volume | 1,895,418 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.41 |
|---|---|
| PEG | 2.71 |
| Price to Sales | 1.02 |
| Price to Book Ratio | -0.34 |
| Enterprise Value to Revenue | -0.33 |
| Enterprise Value to EBIT | 0.18 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.5 |
| Debt to Equity | -0.35 |
Revenue Sources
No data
ESG Score
No data
About FibroGen Inc
CEO: Enrique Conterno